$186 Million is the total value of Northpond Ventures, LLC's 5 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DICE THERAPEUTICS INC | $62,993,000 | -24.4% | 3,292,871 | 0.0% | 33.95% | +16.4% | ||
| DNAY | CODEX DNA INC | $52,863,000 | -50.3% | 9,844,130 | 0.0% | 28.49% | -23.4% | |
| Buy | ISOPLEXIS CORP | $30,213,000 | -62.7% | 8,808,531 | +0.0% | 16.28% | -42.5% | |
| New | VIGIL NEUROSCIENCE INC | $29,628,000 | – | 4,214,498 | +100.0% | 15.97% | – | |
| CANDEL THERAPEUTICS INC | $9,850,000 | -34.9% | 1,935,215 | 0.0% | 5.31% | +0.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TELESIS BIO INC | 8 | Q3 2023 | 37.2% |
| CANDEL THERAPEUTICS INC | 8 | Q3 2023 | 6.0% |
| VIGIL NEUROSCIENCE INC | 7 | Q3 2023 | 65.8% |
| DICE THERAPEUTICS INC | 6 | Q1 2023 | 55.7% |
| ISOPLEXIS CORP | 5 | Q4 2022 | 28.3% |
| PHENOMEX INC | 2 | Q2 2023 | 4.4% |
View Northpond Ventures, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-06-02 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-01 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-15 |
View Northpond Ventures, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.